Results 131 to 140 of about 7,568,653 (278)

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Update on Imaging-based Noninvasive Methods for Assessing Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

open access: yesJournal of Medical Ultrasound
Nonalcoholic fatty liver disease (NAFLD), among the most common chronic liver diseases worldwide, affects approximately 25% of the global population. Its incidence is increasing owing to various risk factors, including genetic variation, metabolic health,
Chia-Chien Kang   +6 more
doaj   +1 more source

Protective Effect of Epigallocatechin‐3‐Gallate Against Fructose‐Induced Metabolic Associated Fatty Liver Disease in Mice by Regulating Ferroptosis and Autophagy via SIRT5

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Metabolic dysfunction‐associated fatty liver disease (MAFLD) lacks effective pharmacological therapies and is strongly associated with excessive fructose consumption. Ferroptosis and autophagy dysregulation are increasingly recognized as key drivers of MAFLD progression.
Puyu Zhang   +11 more
wiley   +1 more source

Primary Biliary Cholangitis Unmasked in Metabolic Dysfunction‐Associated Steatohepatitis: When a Correct Diagnosis Is Incomplete

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yucheng Cheng   +3 more
wiley   +1 more source

Dietary Flavonoid Hyperoside Ameliorates High‐Fat Diet‐Induced Type 2 Diabetes Mellitus by Enhancing Brown Adipose Tissue Thermogenesis, White Adipose Tissue Browning, and Gut Microbiota Remodeling

open access: yesPhytotherapy Research, EarlyView.
Hyperoside ameliorates metabolic dysfunction in high‐fat diet‐induced type 2 diabetic mice, accompanied by enhanced brown adipose tissue thermogenic activity, inguinal white adipose tissue browning‐related changes, reduced M1 macrophage polarization, and gut microbiota remodeling.
WeiFeng Cai   +7 more
wiley   +1 more source

Magnoflorine Ameliorates MASH in Mice Fed a High‐Fat and High‐Fructose Diet by Promoting AMPK‐Mediated Lipophagy and Fatty Acid Oxidation

open access: yesPhytotherapy Research, EarlyView.
Magnoflorine ameliorates metabolic dysfunction‐associated steatohepatitis by promoting AMPKα‐mediated lipophagy and fatty acid oxidation. ABSTRACT Emerging as a significant clinical burden, metabolic dysfunction‐associated steatohepatitis (MASH) continues to challenge global healthcare systems due to limited effective interventions.
Zhengjie Lu   +6 more
wiley   +1 more source

Propolis Supplementation in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesPhytotherapy Research, EarlyView.
In this systematic review and meta‐analysis of four randomized controlled trials (n = 178) of Iranian propolis in adults with MASLD, propolis supplementation was associated with improvement in ultrasound‐assessed hepatic steatosis (three trials, n = 156; RR 2.41, 95% CI 1.59–3.66) and a modest reduction in fasting glucose, with no significant effects ...
Ting‐An Kuo   +4 more
wiley   +1 more source

Redefining Fatty Liver Disease: How Updated Nomenclature Reshapes Clinical Laboratory Diagnostics

open access: yesiLABMED
The nomenclature of fatty liver disease has undergone substantial evolution, transitioning from nonalcoholic fatty liver disease to metabolic‐associated fatty liver disease, and more recently to metabolic dysfunction‐associated steatotic liver disease ...
Ran Wei   +3 more
doaj   +1 more source

Autophagy: a new target for nonalcoholic fatty liver disease therapy

open access: yes, 2016
Yuqing Mao,1 Fujun Yu,1 Jianbo Wang,2 Chuanyong Guo,3 Xiaoming Fan1 1Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, 2Department of Gastroenterology and Hepatology, The Central Hospital of Lishui City ...
Mao YQ, Yu FJ, Wang JB, Guo CY, Fan XM
core  

Natural Bioactive Compounds Targeting Lipid Metabolism in Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesPhytotherapy Research, EarlyView.
The graphical abstract provides a schematic overview of the main topics covered in this review, including lipid metabolism dysfunction in MASLD, the potential regulatory effects of natural bioactive compounds, and the challenges associated with their clinical translation.
Ji‐Kai Ma   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy